The findings revealed a marked elevation in the expression of CLRN3 within tumor specimens in comparison to their normal tissue counterparts (Figure 6a), and this upsurge became more pronounced with advancing pathological stages (Figure 6b). Here, CLRN3 is linked to neoplasm.